
Phosphorylated SIRT1 as a biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis
Keywords: SIRT1; PBMCs; Multiple sclerosis; Histone trimethylation; Glatiramer acetate; Biomarker; AUC; area under the curve; CNS; central nervous system; CPT; cell preparation tubes; EAE; experimental autoimmune encephalomyelitis; EDSS; expanded disability status